Journal of Neurotrauma, 2022 · DOI: 10.1089/neu.2022.0120 · Published: December 1, 2022
This study investigates whether caffeine can enhance the effects of acute intermittent hypoxia (AIH) on walking function in people with chronic incomplete spinal cord injury (iSCI). AIH involves breathing brief episodes of low oxygen, which has shown promise in improving motor function after iSCI. The researchers hypothesized that caffeine, by blocking adenosine receptors, could boost the benefits of AIH. They conducted a double-blind, placebo-controlled study where participants received either caffeine or a placebo before undergoing AIH or a sham treatment. The results showed that participants who received caffeine before AIH experienced greater improvements in walking speed and endurance compared to those who received a placebo. This suggests that caffeine may indeed enhance the effects of AIH in improving walking function after iSCI.
Caffeine pre-treatment may be a useful adjunct to AIH training to augment walking speed in individuals with chronic iSCI.
Genetic factors (CYP1A2 gene variants) may influence the effectiveness of caffeine and AIH combination, suggesting the need for personalized treatment approaches.
Future studies should explore the combination of C+AIH with task-specific gait training to determine if it leads to greater functional gains in overground walking.